Agenus reported $-83290000 in Net Income for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US $ 3179M 2413M
Acceleron Pharma XLRN:US $ -70.46M 6.94M
Amgen AMGN:US $ 1884M 1420M
AstraZeneca AZN:LN -1652M 2202M
Bristol Myers Squibb BMY:US $ 1546M 491M
Celldex Therapeutics CLDX:US $ -20.45M 7.08M
Chemocentryx CCXI:US $ -22.31M 16.9M
CSL CSL:AU $ 565M 1.25B
Dicerna Pharmaceuticals DRNA:US $ -17.07M 23.74M
Eli Lilly And LLY:US $ 1110.1M 280.1M
Flexion Therapeutics FLXN:US $ -30312000 8.1M
Genocea Biosciences GNCA:US $ -3.62M 0.69M
Gilead Sciences GILD:US $ 2592M 1070M
GlaxoSmithKline GSK:LN 1168M 227M
Glaxosmithkline GSK:US $ 1168M 227M
Immunogen IMGN:US $ -37.34M 6.6M
Jiangsu Hengrui Me. 600276:CH CH 1.54B 368.56M
Johnson & Johnson JNJ:US $ 3667M 2611M
Karyopharm Therapeutics KPTI:US $ -51812000 1.77M
Macrogenics MGNX:US $ -52.89M 12.95M
Merck MRK:GR € 761M 16M
Merk MRK:US $ 4567M 3022M
Northwest Biotherapeutics NWBO:US 45.52M 41.11M
Novartis NOVN:VX SF 2758M 138M
Novavax NVAX:US $ -322.43M 29.89M
Pfizer PFE:US $ 8146M 2582M
Regeneron Pharmaceuticals REGN:US $ 1632.2M 1466.7M
Rigel Pharmaceuticals RIGL:US $ -20.95M 7.13M
Sangamo Biosciences SGMO:US $ -47.69M 0.52M
Veracyte VCYT:US $ -14.13M 5.09M
YTE INCY:US $ 181.74M 32.28M